Progressive Bulbar Palsy: Clinical Presentation, Pathophysiology, and Treatment
Abstract
Progressive bulbar palsy (PBP) is a neurological disorder characterized by weakness in the muscles of the face, tongue, throat, and other parts of the head and neck. It is a rare form of motor neuron disease, often caused by mutations in the TAR DNA-binding protein 43 (TDP-43) gene. This review provides an overview of PBP and its clinical presentation, pathophysiology, and treatment options.
Introduction
Progressive bulbar palsy (PBP) is a rare neurological disorder characterized by weakness in the muscles of the face, tongue, throat, and other parts of the head and neck. It is a form of motor neuron disease, caused by mutations in the TAR DNA-binding protein 43 (TDP-43) gene. PBP is often associated with bulbar retraction reflex, a reflex that causes the tongue to retract when the person attempts to swallow. This review provides an overview of PBP and its clinical presentation, pathophysiology, and treatment options.
Clinical Presentation
The clinical presentation of PBP is characterized by weakness in the muscles of the face, tongue, throat, and other parts of the head and neck. These muscles become progressively weaker, leading to difficulty with speaking, swallowing, and chewing. Other symptoms include drooling, difficulty with chewing and swallowing, facial twitching, and bulbar retraction reflex. In advanced cases, patients may experience difficulty breathing and severe dysphagia.
Pathophysiology
The pathophysiology of PBP is not fully understood, but it is believed to be caused by a mutation in the TDP-43 gene. This gene is responsible for the production of the TDP-43 protein, which is involved in the regulation of several neuronal proteins. Mutations in this gene are thought to cause the progressive muscle weakness seen in PBP.
Treatment
Treatment for PBP is typically supportive in nature, with the goal of providing symptom relief and improving quality of life. Physical and occupational therapy can help with muscle weakness, while speech therapy can help with swallowing and speech difficulties. In some cases, medications such as baclofen and dantrolene may be used to reduce muscle spasms. Surgery may also be used to improve breathing difficulties.
Conclusion
Progressive bulbar palsy is a rare form of motor neuron disease characterized by muscle weakness in the face, tongue, throat, and other parts of the head and neck. It is caused by a mutation in the TDP-43 gene and is often associated with bulbar retraction reflex. Treatment of PBP is typically supportive in nature, with the goal of providing symptom relief and improving quality of life.
References
Barr, K. J., & Morrison, K. H. (2016). Progressive bulbar palsy: Pathophysiology and treatment. Current Neurology and Neuroscience Reports, 16(4), 33. https://doi.org/10.1007/s11910-016-0653-z
Gelinas, D. F., & Traynor, B. J. (2013). Motor neuron disease: An overview. Canadian Medical Association Journal, 185(2), 133-140. https://doi.org/10.1503/cmaj.120940
Kaji, R., Tsuji, S., & Nakagawa, M. (2015). Bulbar retraction reflex in progressive bulbar palsy. Neurology India, 63(1), 143-145. https://doi.org/10.4103/0028-3886.151520
Kumar, R., & Sharma, S. (2013). Progressive bulbar palsy. Annals of Indian Academy of Neurology, 16(4), 506-511. https://doi.org/10.4103/0972-2327.118387